Family history and screening for prostate cancer: no evidence of benefit

In what we believe to be the first report of its kind from anywhere in the world, a new paper has reported that there seems to be no evidence that selective screening of men with a family history of prostate cancer is clinically beneficial compared to men with no family history of prostate cancer. … READ MORE …

Most “top-rated” web sites advocate shared decision-making about screening

Despite the recommendations of the USPSTF and others, “Only 17 percent of top-ranked consumer health websites advise against screening for prostate cancer” according to a paper just presented by researchers at the the 2014 Clinical Congress of the American College of Surgeons (ACS), currently ongoing in San Francisco. … READ MORE …

CTFPHC rejects widespread screening for risk of prostate cancer

The Canadian Task Force on Preventive Health Care (CTFPHC) has just issued a guidance document that is not going to make most prostate cancer survivors very happy (either in Canada or elsewhere). … READ MORE …

Expert opinions on prevention, screening, and active surveillance

There are three new and useful resources now available related to the prevention of prostate cancer, screening for prostate cancer, and the role of active surveillance in the expectant management of prostate cancer. … READ MORE …

A guide to PSA screening guidelines

For those who would like to have access to a sound summary of the recommendations of groups around the world on screening for prostate cancer, we can recommend a recent, relatively brief, and straightforward review article recently published in BJU International. … READ MORE …

What a young primary care opinion leader thinks about screening for prostate cancer

In a guest blog post, published yesterday on the MedPage Today web site, Dr. Andrew Buelt, a co-producer of the “Questioning Medicine” podcast for physicians, takes on the issue of screening for prostate cancer. … READ MORE …

D’Amico on the individualization of prostate cancer risk management

In an interesting article in the September 2014 issue of The ASCO Post, Dr. Anthony D’Amico argues in favor of a future in which individualized approaches to risk will replace PSA screening alone as a means of determining who actually needs to be biopsied and (if necessary) receive treatment for clinically significant prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,173 other followers